Telmisartan/Verapamil Hydrochloride

替米沙坦/盐酸维拉帕米

Report date: 2026/04/03 20:03:44

Base Information

Drug NameTelmisartan/Verapamil Hydrochloride
Drug Alias NameHB-01HB-1
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsStress Disorders, Post-TraumaticPanic DisorderMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsYes TelmisartanVerapamil Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHoneybrains Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesHoneybrains Biotech LLC
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticPanic Disorder
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A